Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Health2Sync

Active#10 in Taiwan

Estimated valuation · Diabetes management · Taiwan

Provides a diabetes management app and data platform connecting patients, clinicians, pharma companies and device makers to track glucose, medication and lifestyle data.

Founded2014
HQTaipei
Last roundSeries C · Mar 2025
Country of originTaiwanListed in the Taiwan ranking
Where would you invest?TaiwanJurisdiction as cited by the ranking

Estimated valuation

AI · Taiwan ranking
≈ USD 100MUSD 83–130M · Hundreds of M$
Anchor
Last known equity round: Series C · USD 20M · Mar 2025
AI adjustment
None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Taiwan · all sectorsTop 28#10Edition 0 · October 202621 Jan 2027
Rank historyOct 2026 · #10First edition: no movements yet.

Funding history

DateRoundAmountTypeInvestors
Mar 2025Series CUSD 20MEquityTaiwania Capital, Wistron, Pegatron, BE Health Ventures, Cathay Venture

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Health2Sync as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $100MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in Taiwan

Full Taiwan ranking →

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.